SCHEMBL5657738

SCHEMBL5657738

COc1cc(C=O)c2cc(Cc3ccc(-c4ccccc4)cc3)oc2c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
POLB P06746 2/20 0.42
HTT P42858 2/20 0.42
GAA P10253 1/20 0.42
PDE4B Q07343 1/20 0.40
PDE4D Q08499 1/20 0.40
PDE7A Q13946 1/20 0.40
PDE3A Q14432 1/20 0.40
PDE7B Q9NP56 1/20 0.40
TUBB4A P04350 3/20 0.39
TUBB P07437 3/20 0.39
TUBA3C P0DPH7 3/20 0.39
TUBA1B P68363 3/20 0.39
TUBA4A P68366 3/20 0.39
TUBB4B P68371 3/20 0.39
TUBB3 Q13509 3/20 0.39
TUBB2A Q13885 3/20 0.39
TUBB8 Q3ZCM7 3/20 0.39
TUBA3E Q6PEY2 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659475 0.93 ALDH1A1 (0.48) ALDH1A1KDM4EPOLBHTTGAA
SCHEMBL5657441 0.87 TUBB1 (0.43) ALDH1A1KDM4EPOLBHTTGAA
SCHEMBL5660910 0.86 GPR55 (0.46) ALDH1A1KDM4EPOLBHTTGAA
SCHEMBL5657737 0.82 PDE4B (0.46) ALDH1A1KDM4EPOLBHTTGAA
SCHEMBL5659115 0.82 TUBB4A (0.41) ALDH1A1KDM4EPOLBHTTGAA
SCHEMBL5660061 0.81 ACHE (0.54) ALDH1A1KDM4EGAATUBB4ATUBB
SCHEMBL5722780 0.78 GPR55 (0.43) ALDH1A1KDM4EPOLBHTTGAA
SCHEMBL5660258 0.76 TUBB1 (0.43) ALDH1A1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5656339 0.76 LMNA (0.43) ALDH1A1KDM4EPOLBHTTGAA
Formic Acid SCHEMBL5659524 0.75 MEN1 (0.46) ALDH1A1CYP3A4MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR ALDH1A1 1365/4885KDM4E 1540/4885POLB 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.